De-Risk Drug Development Decision Making

Welcome to the Inaugural Model-Informed Drug Development Summit

Model-Informed Drug Development (MIDD) has rapidly evolved, from a supportive tool to a core driver of decision-making across the entire drug development lifecycle. Backed by the draft ICH M15 guidance and compelling studies showing MIDD can save up to 10 months and $5 million per program, the value is no longer theoretical, it's transformational.

The Model-Informed Drug Development Summit, was a 3-day event featuring 20+ real-world case studies that showcase how MIDD is reshaping the industry.

Delegates discovered how to:

  • Boost efficiency and reduce costs
  • Mitigate risk across development stages
  • Enhance product labeling for real-world impact

Whether you're optimizing existing MIDD strategies or evaluating its potential, this summit was the opportunity to join other pharmacometricians, clinical pharmacologists, and PKPD modelers and explore how MIDD can shift the benefit-risk balance in your favour.

Model-informed drug development is a powerful way to bring clarity and efficiency to the complex process of drug development. I’m looking forward to engaging with others in this event to share insights, deepen our collective understanding, and ultimately help bring impactful therapies to patients faster.

Mahdiar Sadeghi, Senior ScientistDenali Therapeutics

Denali Therapeutics

Model-informed drug development is a powerful way to bring clarity and efficiency to the complex process of drug development. I’m looking forward to engaging with others in this event to share insights, deepen our collective understanding, and ultimately help bring impactful therapies to patients faster.

Mahdiar SadeghiSenior ScientistDenali Therapeutics

Denali Therapeutics

Model-informed drug development is a powerful way to bring clarity and efficiency to the complex process of drug development. I’m looking forward to engaging with others in this event to share insights, deepen our collective understanding, and ultimately help bring impactful therapies to patients faster.

Mahdiar SadeghiSenior ScientistDenali Therapeutics

Denali Therapeutics

Explore the 2025 Full Event Guide

  • Get a full overview of the agenda, speakers, and sessions in one place
  • Preview featured case studies that we’ll be shining a light on
  • Discover exclusive content such as keynote highlights, attendee benefits and more
  • Share easily with colleagues and decision-makers to mobilize interest
Model-Informed Drug Development Summit brochure image

Official Partners

Model-Informed Drug Development Summit brochure image
Quick Download

Attending Companies Include

explore agenda

Explore the Agenda

Hear the latest industry breakthroughs and gain exclusive insights during our packed agenda, interactive roundtables, and panel discussions.

partner w us

Partner With Us

Position yourself alongside other leading solution providers to ensure your brand is at the heart of biopharma deals.

join bio experts

Join Biopharma Experts

Be part of the hottest conversations with like-minded attendees spanning all stages of drug development and make critical connections during our dedicated networking sessions.